QA: Idexx Laboratories INC DE in us_medicinal_products/2022

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0000874716_2023_Idexx_Laboratories_INC_DE.pdf

Logs

info Minor missing amount for aggregate added to remainder industry.us_generic {'aggregate': 'Assets', 'missing_ratio': 0.351206544764992, 'aggregate_val': 3259925000, 'exp_sum': 5024596000, 'exp_to_value': {'AssetsCurrent': 1495254000, 'AssetsNoncurrent': 1764671000, 'PropertyPlantAndEquipmentNet': 702177000, 'Goodwill': 450461000, 'remainder_Assets': 612033000}}
info Minor missing amount for aggregate added to remainder industry.us_generic {'aggregate': 'Liabilities', 'missing_ratio': 0.31695689860470916, 'aggregate_val': 1775395000, 'exp_sum': 2599243000, 'exp_to_value': {'LiabilitiesNoncurrent': 823848000, 'LiabilitiesCurrent': 958782000, 'remainder_Liabilities': 816613000}}
info Minor missing amount for aggregate added to remainder industry.us_generic {'aggregate': 'Assets', 'missing_ratio': 0.3746056798494918, 'aggregate_val': 2746765000, 'exp_sum': 4392053000, 'exp_to_value': {'AssetsCurrent': 1101477000, 'AssetsNoncurrent': 1645288000, 'PropertyPlantAndEquipmentNet': 649474000, 'Goodwill': 459467000, 'remainder_Assets': 536347000}}
info Minor missing amount for aggregate added to remainder industry.us_generic {'aggregate': 'Liabilities', 'missing_ratio': 0.29675984202630507, 'aggregate_val': 2138028000, 'exp_sum': 3040253000, 'exp_to_value': {'LiabilitiesNoncurrent': 902225000, 'LiabilitiesCurrent': 1243953000, 'remainder_Liabilities': 894075000}}
info Added remainder_ComprehensiveNetIncome directly from 10K industry.us_generic {}

Graph

Absolute values for 0000874716, Idexx Laboratories INC DE

  xvar xval
0 LiabilitiesNoncurrent 902,225,000
1 LiabilitiesCurrent 1,243,953,000
2 remainder_Liabilities -8,150,000
3 AssetsCurrent 1,101,477,000
4 AssetsNoncurrent 1,645,288,000
5 PropertyPlantAndEquipmentNet 649,474,000
6 Goodwill 459,467,000
7 remainder_Assets -1,108,941,000
8 GeneralAndAdministrativeExpense 2,213,739,000
9 ResearchAndDevelopmentExpense 254,820,000
10 remainder_Expenses 220,741,000
11 remainder_Revenues 3,368,389,000
12 remainder_NetIncome 0
13 remainder_ComprehensiveNetIncome -24,312,000
  yvar yval
0 Liabilities 2,138,028,000
1 Assets 2,746,765,000
2 Expenses 2,689,300,000
3 Revenues 3,368,389,000
4 StockholdersEquity 608,737,000
5 NetIncome 679,089,000
6 ComprehensiveNetIncome 666,933,000
7 BaseVar 5,483,397,000
8 EconomicCapitalRatiobeforeLimitedLiability 0.615
9 EconomicCapitalRatio 1.39

Edgar->Model Mapping

Feature Distribution

Change over Time